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Summary
The E2F family of transcription factors is critical for the control of cell cycle progression. We now show that the specific
inactivation of E2F3 in mouse embryo fibroblasts (MEFs) results in a disruption of the centrosome duplication cycle. Loss
of E2F3, but not E2F1, E2F2, E2F4, or E2F5 results in unregulated cyclin E-dependent kinase activity, defects in nucleophos-
min B association with centrosomes, and premature centriole separation and duplication. Consequently, this defect leads
to centrosome amplification, mitotic spindle defects, and aneuploidy. Our findings implicate the E2F3 transcription factor
as an important link that orchestrates DNA and centrosome duplication cycles, ensuring the faithful transmission of genetic
material to daughter cells.
Introduction cated once and only once during the cell cycle. While the many
steps involved in centrosome duplication have been elucidated,
little is known about the nature of the activities that normallyThe centrosome directs the polarity of the mitotic spindle and
is essential for the fidelity of chromosome segregation and ge- coordinate this process with the cell cycle. Recent work from
multiple laboratories has demonstrated that the Rb/E2F tran-nomic stability (Pihan and Doxsey, 1999). Normal cells have
one centrosome composed of two tightly associated centrioles, scriptional program is important for the timely expression of
a plethora of genes involved in DNA replication, centrosomesurrounded by an amorphous pericentriolar material. During
transit through G1 to S phase of the cell cycle, the single centri- duplication, DNA repair, and mitosis, consistent with the finding
that loss of E2F1, E2F2, and E2F3 arrest cells at multiple stagesole pair separates and each centriole begins to duplicate. During
S and G2, the two newly formed centriole pairs mature and move of the cell cycle (Ishida et al., 2001; Muller et al., 2001; Ren et
al., 2002; Wu et al., 2001). These results raise the possibility thattoward opposite poles of the nuclear material in preparation
for mitosis (Hinchcliffe and Sluder, 2001). Loss of centrosome the E2F program may serve to coordinate a variety of essential
processes required for the timely and accurate progression ofduplication control, leading to centrosome amplification, has
been associated with most human tumors and is thought to be cells through the cell cycle. We have taken a genetic approach
to dissect the roles played by E2F transcription factors in thea key event in tumor progression of the breast, prostate, and
regulation of the centrosome cycle and find that the E2F3 familycolon (Ghadimi et al., 2000; Lingle et al., 1998, 2002; Lingle
member plays a specific function in the control of this importantand Salisbury, 1999; Pihan et al., 1998). Indeed, centrosome
process.amplification and aneuploidy are common events triggered by
the loss of tumor suppressors such as p53, p21CIP1, GADD45,
ResultsBRCA1, BRCA2, and APC and by the expression of oncogenes
such as Ras, STK15, MAPKK, and Mos (Fodde et al., 2001;
Fukasawa et al., 1996; Fukasawa and Vande Woude, 1997; Loss of E2F3 leads to centrosome amplification
To explore the potential involvement of the E2F transcriptionalHollander et al., 1999; Kaplan et al., 2001; Mantel et al., 1999;
Saavedra et al., 1999, 2000; Tutt et al., 1999; Xu et al., 1999). program in centrosome biology, we derived MEFs from E2F1,
E2F2, E2F3, E2F4, and E2F5 knockout mice (Leone et al., 2001;In order to accurately segregate chromosomes to each of
the daughter cells during mitosis, centrosomes must be dupli- Wu et al., 2001) and assessed the status of centrosomes in
S I G N I F I C A N C E
E2F3 has been shown to play a critical role in the control of S phase entry. Our current finding that the specific loss of E2F3 leads to
aberrant centrosome duplication demonstrates that the E2F3 family member has the unique role of coordinating two important
processes during the cell cycle: DNA and centrosome duplication. Thus, by integrating these two processes during the cell cycle,
E2F3 ensures the accurate transmission of genetic material to each daughter cell. In cancer, however, inactivation of E2F3 may be
a two-edged sword: its loss may decrease the rate of cellular proliferation, but may also lead to genetic instability and thus increase
the metastatic potential of cancer cells.
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Figure 1. Targeted disruption of E2F3 results in centrosome amplification
A: Immunohistochemical analysis of centrosomes from wild-type and E2F3/ cells using a primary -tubulin antibody and a rhodamine-conjugated
secondary antibody (right panel); the left panel shows the same cells stained with DAPI.
B: Percentage of centrosome amplification in early passage (p 2) MEFs of three independent litters (L.1–L.3) of wild-type ( ) and E2F3/ cells (). The first
and second litters include three wild-type and four E2F3/ embryos each; the third litter includes one wild-type and one E2F3/ embryo. Centrosomes
were stained with a monoclonal antibody against -tubulin and a rhodamine-conjugated secondary antibody; the results represent the percentage of
cells with three or more centrosomes.
C: Immunohistochemical analysis of the centrosome status of wild-type and E2F3/ cells using a primary antibody against pericentrin and a rhodamine-
conjugated secondary antibody (right panel); the left panel shows the DAPI-stained mitoses.
D: Percentage of cells with three or more centrosomes from three wild-type and three E2F3/ embryos from two independent litters. Shown are the
percentages resulting from staining wild-type cells ( ) or E2F3/ embryos () with -tubulin (solid bar) or pericentrin (striped bar). For all the graphs
presented in this section, we counted 200 cells per embryo from two different experiments.
early passage cell populations. The E2F3 locus encodes two land, 1997; Zheng et al., 1998). Analysis of E2F3/ MEFs de-
rived from multiple litters revealed that a high proportion of cellsgene products, E2F3a and E2F3b, whose expression is driven
by two different promoters (Leone et al., 2000). Since E2F3a (approximately 60%) in proliferating populations have more than
two centrosomes (Figure 1B), with many cells containing greaterand E2F3b appear to play a dominant role in the control of cell
cycle progression (Leone et al., 1998; Humbert et al., 2000; Wu than four centrosomes (Figure 1A). In contrast, less than 20%
of wild-type cells contained more than two centrosomes (Fig-et al., 2001), we initially analyzed wild-type and E2F3/ MEFs
lacking both E2F3 products. Centrosomes numbers were deter- ures 1A and 1B). This level of centrosome amplification is typical
of wild-type cells and is likely a consequence of cytokinesismined and quantified by immunohistochemistry using antibod-
ies specific for -tubulin, a core component of the centrosome defects that arise upon culturing cells in vitro (Borel et al., 2002;
Meraldi et al., 2002). The severity of the centrosome defect inthat is central to the proper nucleation of the - and -tubulin
subunits of the mitotic spindle (Archer and Solomon, 1994; E2F3/ cells is similar to that previously found in p53/ cells
(Fukasawa et al., 1996; data not shown). ImmunohistochemistryDictenberg et al., 1998; Doxsey et al., 1994; Merdes and Cleve-
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Figure 2. Conditional ablation of E2F3 results in centrosome amplification
A: Western blot analysis of E2F3/ (/) and E2F3f/f (f/f) MEFs infected with control () or Cre-expressing () retroviruses. Arrows indicate endogenous
E2F3a and E2F3b proteins.
B: Fold induction in centrosome amplification in two independent litters (L.1 and L.2) of wild-type ( ) or E2F3f/f () MEFs. Cells were infected with control
() or Cre-expressing () retroviruses as indicated, and centrosomes were stained with a primary antibody against -tubulin and a rhodamine-conjugated
secondary antibody.
using antibodies against pericentrin, another core component and 3B). Generation of E2F3a and E2F3b knockout mice should
clarify the roles played by each of these proteins in the controlof centrosomes (Archer and Solomon, 1994; Dictenberg et al.,
1998; Doxsey et al., 1994; Merdes and Cleveland, 1997; Zheng of the centrosome cycle.
et al., 1998), confirmed the high frequencies of centrosome
amplification in E2F3/ cells detected by -tubulin staining (Fig- Deregulation of the centrosome cycle is specific
to loss of E2F3ures 1C and 1D).
To determine whether centrosome amplification is a direct While E2F3 shares many structural and functional properties
with E2F1 and E2F2, two E2F family members also thought toconsequence resulting from the inactivation of E2F3, we ablated
E2F3 function from MEFs harboring a conditional allele of E2F3 act as transcriptional activators important for promoting cellular
proliferation (Leone et al., 1998; Trimarchi and Lees, 2002), other(E2F3f/f) and assessed the immediate effects on centrosome
numbers. In E2F3f/f MEFs, exon 3, which encodes the DNA experiments indicate that these three family members may have
unique functions in cells (Cloud et al., 2002; DeGregori et al.,binding domain common to both E2F3a and E2F3b, is flanked
by loxP sites. Introduction of the Cre recombinase into these 1997; Field et al., 1996; Humbert et al., 2000; Leone et al., 1998,
2001; Saavedra et al., 2002; Wu et al., 2001; Yamasaki et al.,cells via retroviral vectors results in deletion of exon 3 and
ablation of E2F3a and E2F3b proteins (Wu et al., 2001) (Figure 1996, 1998; Ziebold et al., 2001). To address whether appro-
priate control of the centrosome cycle could also be mediated2A). While expression of Cre in wild-type cells did not result in
centrosome amplification, expression of Cre in E2F3f/f cells led by E2F1 or E2F2, we initially overexpressed these activities and
assessed their ability to alleviate the centrosome amplificationto a similar level of centrosome amplification as that observed
in E2F3/ MEFs (Figure 2B), suggesting that E2F3 plays a cell- defect in E2F3/ cells. As shown in Figure 3C, overexpression
of E2F1 or E2F2 also rescued the centrosome amplificationautonomous role in control of the centrosome cycle.
To confirm that loss of E2F3 is the primary cause for centro- phenotype to the same extent as E2F3a, indicating that these
E2F activities, when overexpressed, are sufficient to significantlysome amplification in E2F3/ MEFs, myc-tagged versions of
E2F3 were reintroduced into E2F3/ MEFs and the centrosome suppress centrosome amplification in E2F3/ MEFs.
Because overexpression studies do not accurately reflectstatus was determined as before. As shown in Figures 3A and
3B, exogenous expression of E2F3a and E2F3b in cells derived the normal function of proteins, we used anti--tubulin antibod-
ies to perform a similar analysis in E2F1/ and E2F2/ MEFsfrom two different E2F3/ embryos significantly suppressed,
in each case, the number of cells harboring more than two as that described above for E2F3/ cells. Analysis of MEFs from
multiple different litters revealed no difference in centrosomecentrosomes. These results demonstrate that centrosome am-
plification is a direct consequence stemming from the loss of numbers between E2F1/, E2F2/, and their wild-type coun-
terparts (Figures 4A and 4B). We also extended our analysis toE2F3 and not from a secondary genetic change that might have
occurred in the generation of E2F3/ cells. Rescue experiments determine a potential role for members of the repressor subclass
of E2F factors, comprised of E2F4 and E2F5, in the control ofwith exogenous E2F3a or E2F3b alone did not yield any insight
as to which E2F3 family member is responsible for preventing centrosome duplication. As shown in Figures 4C and 4D,
E2F4/ and E2F5/ MEFs had a similar frequency of centro-centrosome amplification since overexpression of either E2F3a
or E2F3b protein could rescue to the same extent (Figures 3A some amplification as wild-type littermate cells. Taken together,
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our findings suggest that centrosome amplification is a defect
specific to the loss of the E2F3 family member.
Loss of E2F3 leads to aneuploidy
Since centrosome amplification can lead to spindle defects and
aneuploidy (Fodde et al., 2001; Fukasawa et al., 1996; Fukasawa
and Vande Woude, 1997; Hollander et al., 1999; Kaplan et al.,
2001; Mantel et al., 1999; Saavedra et al., 1999, 2000; Tutt et al.,
1999; Xu et al., 1999), we first investigated whether centrosome
defects in E2F3/ cells were associated with defects in the
assembly of the mitotic spindle. To this end, the microtubule-
nucleation function of centrosomes was determined by immu-
nofluorescence using antibodies specific to -tubulin and
-tubulin. As shown in Figures 5A and 5B, centrosomes in E2F3-
deficient cells colocalized with active sites of microtubule nucle-
ation, often leading to aberrant mitoses.
Aneuploidy, a cellular consequence often associated with
centrosome amplification and mitotic spindle defects, was mea-
sured by two independent methods, the micronucleus assay
and direct chromosome counts. A micronucleus is a chromo-
some or chromosome fragment that is missegregated during
mitosis as a consequence of spindle damage and/or a chromo-
some break, and it appears in the cytoplasm as a DNA-con-
taining sphere surrounded by nuclear membrane. Thus the ex-
tent of micronucleus formation reflects the frequency of cells
in a population that is losing chromosomes (Saavedra et al.,
1999, 2000). Quantification of cells derived from multiple E2F3-
deficient embryos revealed a significant increase in micronu-
cleus formation relative to cells derived from wild-type embryos
(Figure 5C), suggesting that E2F3/ MEFs suffer a higher rate
of chromosome loss. To more directly assess whether loss of
E2F3 can lead to aneuploidy, chromosome numbers were
counted in cells from early and late passage populations. As
expected, analysis of early passage wild-type cells derived from
different litters revealed that the majority of cells contain a 2N
content of DNA (Figures 5D and 6). However, the number of
chromosomes in E2F3/ cells varied among MEF preparations
derived from different litters, with most preparations containing
a near-normal 2N complement of DNA (Figure 5D, top two pan-
els), but some preparations exhibiting clear polyploidy (bottom
panel). At later passages, the distribution of chromosomes in
E2F3/ cells was broadened to include many cells containing
fewer than 40 chromosomes, while wild-type cells retained
mostly a 2N complement of DNA, with a smaller subset of
cells having a 4N complement (Figure 5E, bottom panel). We
Figure 3. Ectopic expression of E2F3a and E2F3b suppresses centrosome conclude from these findings that loss of E2F3 is associated
amplification in E2F3/ MEFs with increased genetic instability and aneuploidy.
A: Western blot analysis of protein lysates from two litters (L.1, L.2) of
wild-type or E2F3/ cells infected with control (C), myc-E2F3a-expressing E2F3/ cells have a functional
(3a), myc-E2F3b-expressing (3b), or with both myc-E2F3a- and myc-
G1/S tetraploidy checkpointE2F3b-expressing (3a/b) retroviruses. Cell lysates were subjected to SDS-
Recent observations suggest that more than one model mayPAGE, transferred unto PDVF membranes, and probed with an antibody
that recognizes the myc epitope of the myc-tagged E2F3a and E2F3b explain how centrosome amplification occurs (Borel et al., 2002;
proteins. Meraldi et al., 2002; Tarapore et al., 2001). One of the models
B: Fold induction of centrosome amplification in wild-type ( ) or E2F3/
proposes that direct deregulation of the centrosome duplication() cells. MEFs were infected with retroviruses as in (A), and centrosomes
cycle can lead to centrosome amplification (Tarapore et al.,were stained with a primary antibody against -tubulin and a rhoda-
mine-conjugated secondary antibody. 2001). The other model proposes that defective cytokinesis can
C: Fold induction of centrosome amplification in wild-type ( ) or E2F3/ result in binucleation and the inheritance of two pairs of centro-
() cells infected as in (A), except that parallel plates were infected somes, leading to the amplification of centrosomes during sub-with retroviruses expressing HA-hE2F1 (1) or HA-hE2F2 (2).
sequent cell cycles (Borel et al., 2002; Meraldi et al., 2002). To
determine whether this latter mechanism may be responsible
for centrosome amplification in E2F3/ cells, we assessed gross
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Figure 4. Centrosome amplification is specific to
loss of E2F3
A: Percentage of centrosome amplification in
wild-type ( ) or E2F1/ () MEFs from two inde-
pendent litters (L.1 and L.2).
B: Percentage of centrosome amplification in
wild-type ( ) or E2F2/ () MEFs from two inde-
pendent litters (L.1 and L.2).
C: Percentage of centrosome amplification in
wild-type ( ) or E2F4/ () MEFs from two inde-
pendent litters (L.1 and L.2).
D: Percentage of centrosome amplification in
wild-type ( ) or E2F5/ () MEFs from two inde-
pendent litters (L.1 and L.2). Centrosomes from
early passage (p 2) MEFs were stained with a
primary -tubulin antibody and a rhodamine-
conjugated secondary antibody.
ploidy status in these cells by flow cytometry. This analysis function are unlikely to account for the centrosome amplification
revealed a DNA content in E2F3/ cells that was almost identical defects observed in E2F3/ cells.
to that of wild-type cells (Figures 6A and 6B), suggesting that
loss of E2F3 does not lead to increased multinucleation in the E2F3 controls cyclin E expression
population. and centriole separation
To explore whether G1/S checkpoint function was intact in A number of other reasons could account for the abnormally
E2F3/ MEFs, cells were treated with nocodazole, dihydrocyto- high number of centrosomes observed in E2F3-deficient cells,
chalasin B (DCB; data not shown), or DCB followed by nocoda- including premature centriole separation or centrosome redupli-
zole as described previously (Borel et al., 2002; Lanni and Jacks, cation. One of the first steps required before the onset of centro-
1998). Nocodazole prevents polymerization of the - and some duplication is the phosphorylation, by cyclin E-dependent
˜-tubulin subunits of the mitotic spindle, whereas DCB disrupts kinase activity, of nucleophosmin B at threonine 199 (T199).
the normal formation of a contractile actin ring necessary for
Phosphorylation at T199 leads to the release of nucleophosmin
proper cytokinesis (Aubin et al., 1981; Martineau et al., 1995).
B from centrosomes and the separation of paired centriolesSince loss of either Rb or p53 is known to abrogate G1/S check-
(Okuda et al., 2000). In its unphosphorylated state, nucleophos-point function (Di Leonardo et al., 1997, Lanni and Jacks, 1998;
min B remains associated with centrosomes and is thought toNiculescu et al., 1998), Rb/ and p53/ fibroblasts were utilized
prevent the separation of paired centrioles and thus precludeas controls for this assay. Treatment of wild-type or E2F3/
centrosome duplication. In previous studies, we demonstratedcells with nocodazole, or DCB followed by nocodazole, resulted
that the concerted ablation of E2F1, E2F2, and E2F3 proteinsin the accumulation of cells with a 4N content of DNA (Figure
from MEFs led to an increase in cyclin E mRNA levels (Wu et al.,6C). As expected, similar treatment of Rb/ or p53/ cells led
2001); however, the identity of the specific E2F family memberto an accumulation of cells with DNA contents higher than 4N.
responsible for regulating cyclin E expression was not investi-Taken together, these experiments suggest that E2F3/ cells
gated. Nonetheless, these observations raised the possibilityare not multinucleated and have an intact G1/S tetraploidy
checkpoint. Therefore, defects in cytokinesis or checkpoint that deregulated cyclin E expression could be a contributing
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Figure 5. Loss of E2F3 results in aneuploidy
A: Spindle abnormalities were detected by
coimmunostaining the mitotic asters with a pri-
mary antibody against -tubulin and an ALEXA-
488-conjugated secondary antibody (shown in
green), and the centrosomes with a primary anti-
body against -tubulin and a rhodamine-conju-
gated secondary antibody (shown in red). The
left panel shows a wild-type cell in metaphase
with two centrosomes and a normal, bipolar mi-
totic spindle; the middle and right panel show
two E2F3/ cells with multipolar mitotic spindles.
B: Percentage of wild-type ( ) or E2F3/ ()
mitotic cells with abnormal multipolar spindles.
C: Percentage of wild-type ( ) and E2F3/ ()
cells containing micronuclei. MEFs derived from
three wild-type and four E2F3/ embryos from
one litter are presented. The results were derived
from counting 2000 cells in interphase per group
(from duplicate plates).
D: Analysis of ploidy in early passage (p 2) wild-
type (left panels) and E2F3/ (right panels) MEFs.
E: Analysis of ploidy in late passage (p 7) wild-
type (left panel) or E2F3/ (right panel) MEFs. At
least 50 chromosome spreads were counted per
group. Each pair of panels represents wild-type
and E2F3/ MEFs from the same litter. The four
pairs presented are from independent litters.
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Figure 6. Loss of E2F3 does not result in multinucleation or failure of the tetraploidy checkpoint
A: Flow cytometric analysis of various early passage mouse embryonic fibroblasts (MEFs). Passage 2 wt or E2F3/ MEFs were processed as described in
Experimental Procedures and analyzed by flow cytometry. Shown are the flow cytometric analyses of cells, showing their respective DNA contents (2N,
4N, or 8N).
B: Quantitative analysis of the percentage of passage 2 wt or E2F3/ MEF cells with the indicated DNA contents. Values indicate cells with 2N (), 4N ( ),
or 8N () DNA contents  the standard deviation between four embryos from independent litters.
C: Flow cytometric analysis of control, nocodazole, or DCB and nocodazole-treated MEFs. Passage 5 wt, p53/, rb/, or E2F3/ MEFs were left untreated
or were treated with nocodazole for 72 hr, or with DCB for 36 hr followed by nocodazole treatment for 36 hr. Shown are cells with a 2N, 4N, 8N, or 16N
DNA content.
factor toward the centrosome amplification observed in E2F3/ increase was specific to the loss of E2F3 since disruption of
each of the other E2Fs had no effect on cyclin E protein levelsMEFs.
To first determine whether the loss of E2F3 may lead to (Figure 7B). Concordant with an increase in cyclin E protein,
cyclin E-dependent kinase activity was modestly, but reproduci-deregulated cyclin E expression, we analyzed cyclin E protein
levels in wild-type and E2F3-deficient MEFs by Western blot bly elevated in quiescent E2F3/ cells (Figure 7C). Moreover,
while cyclin E-dependent kinase activity in wild-type cells couldassays. As shown in Figure 7A, cyclin E but not cdk2 protein
levels were consistently higher in both quiescent and proliferat- be significantly induced by serum-mediated growth stimulation,
further activation in E2F3/ cells was minimal.ing E2F3/ cells than in wild-type control cells. This observed
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Figure 7. Loss of E2F3 leads to premature cyclin E-dependent kinase activation
A: Western blot analysis showing Cyclin E (top panel) or Cdk2 (as a loading control, bottom panel) protein levels in proliferating and starved wild-type and
E2F3/ cells.
B: Western blot analysis showing Cyclin E protein levels in serum-starved wild-type, E2F1/, E2F2/, E2F3/, E2F4/, and E2F5/ cells. The bottom panel
shows -tubulin levels, used as loading controls. The lysate from E2F3/ MEFs presented were derived from a different litter than the ones shown in (B).
C: Relative activity of cyclin E-dependent kinase in protein lysates derived from starved and proliferating wild-type and E2F3/ cells, using histone-1 (H1)
as a substrate.
D: Western blot analysis of isolated GST-tagged wt nucleophosmin B (GST-NPM/wt) or a GST-tagged mutant nucleophosmin, in which the threonine 199
site was changed to alanine (GST-NPM/T199A). The left panel shows the coomassie-stained gel to show the equal loading of protein, and the right panel
a Western blot probed with an antibody against phospho-T199 nucleophosmin B.
E: Western blot analysis of nuclear and cytoplasmic protein fractions from serum-starved wt or E2F3/ MEFs. The Western blot was probed with the antibody
described in (D). To ensure that equal loading was achieved, the same membrane was probed with -tubulin.
F: wt and E2F3/ cells were cultured under serum starvation conditions and released from the G1 block by serum addition. Nuclear or cytoplasmic fractions
were obtained 0, 4, and 16 hr after serum addition. The Western blot was probed with the same antibody used in (D) and (E). As a loading control, we
probed the same membrane with an antibody against total nucleophosmin (NPM).
Considering the established link between cyclin E-depen- for the T199-phosphorylated form of nucleophosmin to assess
its phosphorylation status in E2F3/ cells. To test the specificitydent phosphorylation of nucleophosmin and centrosome dupli-
cation, our results raised the possibility that deregulated cyclin of this antibody, purified GST-tagged wild-type or mutant
nucleophosmin, in which threonine 199 was changed to alanineE activity in E2F3-deficient cells could result in the untimely
phosphorylation and release of nucleophosmin B from centro- (T199A), was preincubated with purified cyclin E-cdk2 com-
plexes and then subjected to SDS-PAGE. Commassie bluesomes, leading to premature centriole separation and duplica-
tion. To explore this possibility, we used an antibody specific staining of blots demonstrated equal loading of proteins into
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gels (Figure 7D, left panel). Importantly, the anti-phospho-T199- of wild-type and 20% of E2F3/ MEFs contained one undupli-
cated centrosome (Figure 8E, top panel). Interestingly, a highspecific nucleophosmin antibody recognized the wild-type but
not the mutant form of nucleophosmin by Western blot analysis proportion of the quiescent E2F3/ MEFs containing separated
centrioles were in the process of duplicating their centrosomes,(Figure 7D, right panel), demonstrating the specificity of these
antibodies for the T199-phosphorylated form of nucleophosmin. as indicated by the presence of a growing nascent daughter
centriole adjacent to the larger original centriole (Figures 8DUsing these specific antibodies, we next explored the phos-
phorylation status of nucleophosmin in E2F3/ cells synchro- [see arrow in bottom panel] and 8E). These observations suggest
that separated centrosomes in E2F3/ MEFs can undergo cen-nized by serum deprivation. As shown in Figure 7E, quiescent
E2F3/ cells had increased levels of phospho-T199 nucleo- trosome duplication prematurely. The premature separation of
centrosomes in E2F3/ MEFs was not due to the inability ofphosmin relative to wild-type cells. Serum stimulation of quies-
cent wild-type cells into the cell cycle resulted in an accumula- E2F3 null cells to undergo growth-arrest under these conditions,
as very few of these cells continued to replicate their DNA (2%tion of phospho-T199 nucleophosmin that peaked by 16 hr
post induction. In contrast, further increases in phospho-T199 of cells were BrdU positive; Figure 8E). Together, these findings
suggest that inappropriately high levels of cyclin E-dependentnucleophosmin were not observed in E2F3/ serum-stimulated
cells. The T199 phosphorylation status of nucleophosmin during kinase activity in quiescent E2F3/ cells may result in the phos-
phorylation and release of nucleophosmin from centrosomes,the cell cycle of wild-type and mutant cells was consistent with
the observed cyclin E-dependent kinase activity in these cells leading to centriole separation and premature centrosome dupli-
cation, and eventually to centrosome amplification.(compare with Figure 7C, and data not shown). While in all
cases the total levels of nucleophosmin protein did not vary
significantly, we were unable to detect any phospho-nucleopho- Discussion
smin in cytoplasmic fractions of serum-stimulated E2F3/ cells,
the significance of which remains to be examined. Genome-wide analysis of gene expression suggests that E2F
regulates the expression of genes involved in G1/S progressionWe then compared the association of nucleophosmin B
with centrosomes in quiescent wild-type and E2F3/ cells by and DNA replication, as well as the expression of genes involved
in apoptosis, DNA repair, and mitosis (Ishida et al., 2001; Mullerimmunostaining cells with nucleophosmin B-specific and -tubu-
lin-specific antibodies (Okuda et al., 2000). As reported pre- et al., 2001; Ren et al., 2002). Recent observations have revealed
extensive complexity among the E2F family of transcription fac-viously, nucleophosmin localized to essentially all the undupli-
cated centrosomes in wild-type cells (Okuda et al., 2000) tors. While E2F4 and E2F5 are required in mediating a p16INK4a-
induced cell growth arrest, the E2F1, E2F2 and E2F3 members(99%; Figures 8A and 8B). In contrast, nucleophosmin local-
ized to only half of the unduplicated centrosomes in E2F3/ are essential for cell cycle progression and cellular proliferation
(Gaubatz et al., 2000; Wu et al., 2001). Moreover, the expressioncells (55%). Since quiescent E2F3/ cells have a significantly
lower proportion of unduplicated centrosomes relative to wild- and activities of the various E2F family members can be regu-
lated by each other (Trimarchi and Lees, 2002). Our presenttype cells (20% versus 55%, respectively), the actual fraction
of cells containing centrosome-associated nucleophosmin is work identifies and describes a function that is unique to the
E2F3 gene in regulating the centrosome duplication cycle. Wesignificantly lower in E2F3/ than that in wild-type cells (Figure
8C). These data demonstrate that inactivation of E2F3 results find that inactivation of E2F3 leads to an increase in cyclin E
expression, inappropriate cyclin E-dependent kinase activation,in defects in nucleophosmin association with centrosomes. We
propose that inappropriate cyclin E-dependent kinase activation and a defect in nucleophosmin B association with unduplicated
centrosomes. These events appear to result in premature centri-and phosphorylation of nucleophosmin in E2F3/ cells may
lead to the premature release of nucleophosmin from undupli- ole separation and duplication, centrosome amplification, and
genetic instability. While E2F3 has been shown to be critical forcated centrosomes or, alternatively, to the improper loading of
nucleophosmin on centrosomes during the previous mitosis. DNA replication and normal cellular proliferation, and thus its
loss may be expected to decrease cellular proliferation rates ofFinally, centrosomes in wild-type and E2F3/ cells were
also visualized by the introduction of a GFP-tagged version of cancer cells (Leone et al.; 1998, 2001; Humbert et al., 2000;
Wu et al., 2001), its loss would also promote genetic instabilitycentrin-2 (GFP-centrin), an essential component of centrioles.
There are two main advantages in analyzing centrosomes in and, paradoxically, may enhance the metastatic potential of
tumor cells.cells expressing GFP-centrin-2. One advantage is that centro-
somes can be visualized and quantified during interphase. A Previous observations indicated a role for the E2F transcrip-
tional program in the control of centrosome biology. Initial cluessecond advantage is that the resolution of its visualization by
direct immunofluorescent microscopy is sufficient to discrimi- from studies using hydroxyurea-arrested tumor cells suggested
that centrosome reduplication could be inhibited by a nonphos-nate between centriole pairs, single separated centrioles, and
separated centrioles with an associated nascent centriole as phorylatable form of Rb or by p16INK4a (Meraldi et al., 1999). In
addition, introduction of the papilloma virus E7 oncogene intothey begin to duplicate (White et al., 2000). Wild-type and
E2F3/ cells were thus infected with a retrovirus vector ex- primary human fibroblasts was shown to induce centrosome
amplification (Duensing et al., 2000). More recently, genome-pressing GFP-centrin-2, brought to quiescence by density ar-
rest, fixed and visualized by fluorescent microscopy. Cells were wide microarray analysis revealed that loss of the p107 and p130
pocket proteins can lead to the upregulation of nek2 expressionclassified as having one centrosome if GFP-positive centrioles
were tightly paired (Figure 8D; top right panel) and as having (Ren et al., 2002), and that overexpression of E2Fs can lead to
the activation of RanBP (Muller et al., 2001); nek2 and RanBPtwo or more centrosomes if the centrioles were separated or
amplified (Figure 8D; middle and bottom right panels, respec- are two genes whose products localize to centrosomes and
affect centriole cohesion and microtubule nucleation, respec-tively). Under density-arrested conditions, approximately 45%
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Figure 8. Deregulation of cyclin E-dependent kinase activity in E2F3/ cells leads to premature centriole separation
A: Coimmunostaining of -tubulin (middle panels) and nucleophosmin B (right panels) in cells cultured under serum-starvation conditions.
B: Percentage of nucleophosmin B-positive unduplicated centrosomes in wild-type ( ) or E2F3/() cells under serum starvation conditions.
C: Percentage of cells with nucleophosmin B-positive centrosomes in the total population of wild-type ( ) or E2F3/() cells cultured under serum starvation.
D: Wild-type and E2F3/ cells expressing GFP-centrin-2. Shown from top to bottom: a wild-type cell with an unduplicated centrosome, prior to the separation
of centrioles; an E2F3/ cell with a separated centrosome; an E2F3/ cell with multiple, separated centrioles. The left panels show the corresponding
DAPI-stained nuclei. White arrows indicate individual centrioles while the red arrow indicates a separated centriole associated with a nascent centriole.
E: Top panel, percentage of wild-type ( ) or E2F3/ cells () containing one (solid bars) or 2 separated centrosomes. Bottom panel, percentage of
wild-type ( ) or E2F3/ cells () containing unduplicated (solid bars), 2 separated and unduplicated (stripes), or  2 separated and duplicated
centrosomes (dotted) in density-arrested conditions. Centrioles were visualized using GFP-centrin-2, and the calculated percentages are based on the
results from counting 100 cells. Shown in parenthesis are the percentage of BrdU-positive cells in the population.
tively (Carazo-Salas et al., 2001; Meraldi et al., 1999; Wilde centrosome duplication cycle and the cell cycle (Tarapore et
al., 2001). Recent observations have revealed that defects inand Zheng, 1999). Whether these and other centrosome-related
genes are specific transcriptional targets regulated by E2F3 cytokinesis may also lead to polyploidy and the acquisition of
more than one centrosome per daughter cell, leading to centro-remains to be determined.
Recent publications (Borel et al., 2002; Meraldi et al., 2002; some amplification (Borel et al., 2002; Meraldi et al., 2002). The
fact that early passage E2F3/ cells have similar DNA contentsTarapore et al., 2001) have proposed two models to explain
how centrosome amplification may occur. The first model sug- as wild-type cells suggests that loss of E2F3 does not induce
major changes in ploidy. Moreover, E2F3-deficient cells havegests that loss of tumor suppressor function, such as p53,
leads to centrosome amplification by the uncoupling of the a competent G1/S tetraploidy checkpoint since they arrest nor-
342 CANCER CELL : APRIL 2003
A R T I C L E
mally when challenged with agents that disrupt spindle forma- trosomes late in G1, allowing centriole separation and duplica-
tion (nocodazole) or cytokinesis (DCB). Together with the ob- tion to occur as cells progress through G1/S and S phase,
servation that E2F3/ cells have increased frequencies of respectively (Okuda et al., 2000). Cyclin E/cdk2 also phosphory-
separated centrosomes that are often associated with nascent lates and stabilizes mMsp1p (esk2), a protein kinase required
daughter centrioles, these findings suggest that loss of E2F3 subsequent to centriole separation for the formation of nascent
leads to increased centrosome amplification by inducing a de- centrioles (Fisk and Winey, 2001). Additionally, cyclin E/cdk2
fective centrosome duplication cycle, rather than indirectly by can phosphorylate CP110, a protein that plays a critical role in
affecting ploidy or cytokinesis. Even though we believe that the promoting duplication of centrosomes (Chen et al., 2002). While
micronucleus formation in E2F3/ cells is due to increases in our data support a role for deregulated cyclin E activity in medi-
spindle abnormalities, we have not yet ruled out whether the ating centrosome amplification in E2F3/ cells, the premature
micronuclei formation is due to other possible mechanisms such induction of cyclin E/cdk2 activity is not likely the sole factor
as defects in the spindle assembly checkpoint machinery responsible for this phenomenon, as overexpression of cyclin
(Amon, 1999) or the induction of chromosome breaks, a mecha- E has been shown to result in only modest increases in centro-
nism commonly associated with the expression of certain onco- some amplification (Mussman et al., 2000; Spruck et al., 1999).
genes such as Ras (Denko et al., 1994; Saavedra et al., 1999, Moreover, the inactivation of Rb, which also results in the prema-
2000). ture activation of cyclin E/cdk2, does not lead to centrosome
How might E2F3 regulate the centrosome duplication cycle? amplification to any appreciable extent and does not increase
The E2F3 locus encodes for two gene products, E2F3a and
the frequency of centrosome amplification induced by loss of
E2F3b (Leone et al., 2000), which differ in their expression pat-
E2F3 (Fukasawa et al., 1996; and data not shown). Nonetheless,
terns during the cell cycle. E2F3a protein levels oscillate during
the finding that the specific loss of E2F3 function perturbs boththe cell cycle, reaching peak levels late in G1 and early S phase, a
the centrosome cycle (this study) and cell cycle kinetics (Hum-time when E2F target genes are maximally activated. In contrast,
bert et al., 2000; Wu et al., 2001) suggests that this E2F familyE2F3b protein is constant throughout the cell cycle and can be
member is unique in its ability to impact on two cellular pro-found in association with Rb during G0 (Leone et al., 1998,
cesses whose timing of execution is crucial for the maintenance2000). These properties of the E2F3s have led to the suggestion
of genomic stability: centrosome duplication and DNA repli-that E2F3a may function as an activator, and E2F3b as a repres-
cation.sor of transcription, and thus these two E2F3 isoforms may have
In summary, our results identify and define a specific roleopposing roles in the control of cell proliferation. Consistent with
for E2F3 in the control of the centrosome duplication cycle. E2F3this notion, the targeted inactivation of both E2F3a and E2F3b
may thus be viewed as an activity important for coordinating twomay lead to a decrease in expression of many E2F target genes
critical processes during the cell cycle, DNA replication andand an increase in others (such as cyclin E) (Wu et al., 2001).
centrosome duplication, and as such represents a key activityWe speculate that the E2F3 locus regulates centrosome dupli-
essential for the appropriate segregation of genetic material tocation in two ways. First, E2F3b, by mediating the repression
of cyclin E, may prevent the premature activation of cyclin E/ each daughter cell.
cdk2, phosphorylation of nucleophosmin B, and separation of
Experimental procedurescentrioles. Second, E2F3a, by activating the expression of G1/
S-specific genes involved in the inhibition of centrosome rerepli-
Generation of mouse embryonic fibroblastscation (such as BRCA1, Wang et al., 2000; Xu et al., 1999) may
The generation of the conventional (E2F3/) and the conditional (E2F3f/f)prevent the inappropriate reduplication of centrosomes. Thus,
E2F3 knockout mice has been described previously (Leone et al., 2001; Wu
loss of E2F3a and E2F3b function may disrupt the coordinated et al., 2001). The E2F1/, E2F2/, E2F4(/), and E2F5(/) mice were a
expression of activities required for the timely duplication of generous gift from Dr. Michael Greenberg and Drs. Stuart Orkin, Joseph
centrosomes, leading to premature centrosome duplication and Nevins, and David Livingston, respectively. All the mouse embryonic fibro-
amplification. While overexpression of E2Fs can partly restore blasts (MEFs) utilized in this study were generated from 13.5 day embryos
of a mixed 129/Sv and C57Bl6 background, where the individual contribu-normal centrosome numbers in E2F3/ cells, overexpression
tions of both genetic backgrounds were similar. Unless otherwise specified,studies are difficult to interpret, and the analysis of E2F-deficient
MEFs were cultured in 15% FBS/DMEM in an atmosphere of 5.5%–6% CO2.cells clearly demonstrates that E2F3 is unique in its ability to
impact on the centrosome duplication cycle. At least in part,
Immunohistochemistryfunctional specificity among E2Fs in the control of centrosome
MEFs were plated at 4	 104 cells per well into 2-well tissue culture chamber
duplication may reflect their ability to regulate distinct subsets slides and grown for 2–3 days. Cells were fixed in cold 4% parafolmaldehyde,
of target genes (DeGregori et al., 1997; Ishida et al., 2001; washed in PBS, permeabilized in 1% NP40/PBS solution, and blocked in
Moroni et al., 2001; Muller et al., 2001). The generation of mice 5% BSA in PBS. Centrosomes were stained overnight at 4
C with monoclonal
and cells deficient for the individual E2F3s should provide impor- antibodies against pericentrin (Transduction Laboratories) or -tubulin
(Sigma) and an anti-mouse rhodamine-conjugated secondary antibodytant insights on how this transcriptional program regulates cen-
(Pierce). The mitotic spindle was stained with -tubulin (Sigma) and an Alexatrosome duplication.
488-conjugated secondary antibody (Molecular Probes). The nucleophosminThe observed alterations in the centrosome cycle of E2F3/
B and -tubulin colocalization was achieved by fixing the cells with metha-cells are consistent with previous roles proposed for cyclin
nol:acetone (1:1), blocking with 15% goat serum, and staining with rhoda-E-dependent kinase activity in the regulation of centrosome
mine-conjugated anti-mouse and Alexa 488-conjugated anti-rabbit second-
duplication (Hinchcliffe et al., 1999; Lacey et al., 1999; Matsu- ary antibodies, respectively. Cells were washed in PBS and counterstained
moto et al., 1999; Meraldi et al., 1999). Cyclin E/cdk2 has been with 4,6-diamidino-2-phenylindole (DAPI). For each experiment involving
shown to phosphorylate nucleophosmin B on threonine 199, calculations of the frequencies of centrosome or spindle defects, at least
100 cells from each of two or more chambers were counted per group.an event that promotes nucleophosmin B dissociation from cen-
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Proliferation assays with a similar morphology to the nucleus except that their sizes range from
1/10th to 1/100th the size of a nucleus; 1000 cells were counted for eachFor the serum arrest experiments, 8 	 104 cells were plated into 60 mm
tissue culture plates, allowed to attach for 16 hr, and then incubated in genotype analyzed. To calculate ploidy, we obtained chromosomes by stan-
dard procedures. Briefly, asynchronously growing cells were treated withmedium containing 0.2% fetal bovine serum (FBS) for 60 hr. For the density
arrest experiments, cells were allowed to remain contact inhibited for 48 hr. colcemid to inhibit the formation of the mitotic spindle, collected, and placed
BrdU was added to the medium in order to determine the efficacy of the in a hypotonic solution. After fixation in methanol:acetic acid (3:1 ratio), cells
density and serum arrest, and BrdU incorporation was determined as de- were dropped into glass coverslips and stained with DAPI. At least 100
scribed previously (Leone et al., 1998). Briefly, cells were fixed in a 1:1 chromosome spreads per group were analyzed.
methanol:acetone solution, rinsed twice with PBS, and treated with 1.5 N
HCl. BrdU incorporation was detected using a primary anti-BrdU antibody Flow cytometric analysis
and a rhodamine-conjugated secondary antibody; nuclei were counter- Flow cytometry was done as previously described (Leone et al., 1998).
stained with DAPI. The percentage of BrdU-positive cells was obtained from Briefly, cells were collected, fixed in 70% ethanol, resuspended in PBS,
the analysis of at least 500 nuclei per time point. treated with 2N HCl containing 0.2 mg/ml pepsin, and neutralized with 0.1
M sodium tetraborate. Following washes with PBS, cells were incubated in
Retroviral infections RNase A (0.5 mg/ml) and propidium iodide (50 g/ml), diluted to an equal
The retroviral constructs utilized in this study were generated by standard concentration, and analyzed by flow cytometry. For the endoreduplication
cloning techniques. We utilized the following constructs in our study: pBABE- assays, cells were treated with nocodazole alone at a concentration of 0.125
puro, pBABEhygro, pBABEpuro-CRE, pBABEhygro-E2F3a (myc-tagged), g/ml, as described in Lanni and Jacks (1998), or medium, for 72 hr. Parallel
pBABEhygro-E2F3b (myc-tagged), pBABEpuro-hE2F1 (HA-tagged), pBA- plates were treated with DCB (10 M) for 36 hr or with DCB for 36 hr followed
BEpuro-hE2F2 (HA-tagged), and pBABEhygro-GFP-centrin-2. Constructs by nocodazole treatment for 36 hr (Borel et al., 2002). Cells were then
were transfected into ecotropic Phoenix cells by the CaCl2 procedure and analyzed for flow cytometry.
high-titer viruses were harvested 48 and 60 hr after transfection. Primary
MEFs were incubated with medium from the transfected Phoenix cells con- Acknowledgments
taining the indicated retroviruses and 4 g/ml polybrene. Twenty-four hours
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Western blot and kinase assays
Protein lysates were obtained by incubating cells in gel shift lysis buffer (50
mM HEPES; pH 7.9; 250 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA; 0.1% NP40
and 10% glycerol; 0.5 mM NaF; 0.1 mM NaVO4; 0.1 mM PMSF; 10 mM Received: August 29, 2002
-glycerophosphate; 0.1 mM DTT; 0.1 mg/ml aprotinin; 0.1 mg/ml leupeptin) Revised: March 20, 2003
for 20 min at 4
C. Proteins were separated in SDS polyacrylamide gels and Published: April 21, 2003
transferred to polyvinylidene fluoride membranes. Blots were blocked with
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centrosomes arise from tetraploidy checkpoint failure and mitotic centro-tonic lysis buffer (10 mM HEPES; pH 7.5; 10 mM KCl; 3 mM MgCl2; 0.05%;
some clusters in p53 and RB pocket protein-compromised cells. Proc. Natl.1mM EDTA; 0.5 mM NaF; 0.1 mM NaVO4; 0.1 mM PMSF; 10 mM
Acad. Sci. USA 99, 9819–9824.-glycerophosphate; 0.1 mM DTT; 0.1 mg/ml aprotinin; 0.1 mg/ml leupeptin)
for 20 min at 4
C. Nuclear lysates were obtained by incubating the pellets Carazo-Salas, R.E., Gruss, O.J., Mattaj, I.W., and Karsenti, E. (2001). Ran-
remaining from the cytoplasmic extractions in gel lysis buffer for 20 min at GTP coordinates regulation of microtubule nucleation and dynamics during
4
C. Primary antibodies were detected using a horseradish peroxidase- mitotic-spindle assembly. Nat. Cell Biol. 3, 228–234.
conjugated secondary antibody and the ECL reagent (Amersham). For de-
Chen, Z., Indjeian, V.B., McManus, M., Wang, L., and Dynlacht, B.D. (2002).termining the specificity of the Cdk2-dependent phosphorylation of nucleo-
CP110, a cell cycle-dependent CDK substrate, regulates centrosome dupli-phosmin, GST-NPM/wt and GST-NPM/T199A (thr199 is replaced by ala)
cation in human cells. Dev. Cell 3, 339–350.were subjected to in vitro kinase reaction with Cdk2/cyclin E purified from
baculovirus, as described previously (Okuda et al., 2000; Tokuyama et al., Cloud, J.E., Rogers, C., Reza, T.L., Ziebold, U., Stone, J.R., Picard, M.H.,
2001). The reaction mixtures were run on SDS-PAGE, transferred onto a Caron, A.M., Bronson, R.T., and Lees, J.A. (2002). Mutant mouse models
membrane, and immunoblotted with anti-phosphoT199/NPM antibody. Ki- reveal the relative roles of E2F1 and E2F3 in vivo. Mol. Cell. Biol. 22, 2663–
nase assays using histone 1 (H1) were performed as described previously 2672.
(Leone et al., 1998).
DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. (1997). Distinct
roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad.Analysis of ploidy
Sci. USA 94, 7245–7250.The micronucleus assay was done as described previously (Saavedra et al.,
1999, 2000). Briefly, 4 	 104 cells were plated into each well of a 2-well Denko, N.C., Giaccia, A.J., Stringer, J.R., and Stambrook, P.J. (1994). The
chamber slide (Falcon). After 48 hr in culture, cells were fixed in 4% paraform- human Ha-ras oncogene induces genomic instability in murine fibroblasts
within one cell cycle. Proc. Natl. Acad. Sci. USA 24, 5124–5128.aldehyde and stained with DAPI. Micronuclei appear as spherical structures
344 CANCER CELL : APRIL 2003
A R T I C L E
Dictenberg, J.B., Zimmerman, W., Sparks, C.A., Young, A., Vidair, C., Zheng, postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055–
1064.Y., Carrington, W., Fay, F.S., and Doxsey, S.J. (1998). Pericentrin and
gamma-tubulin form a protein complex and are organized into a novel lattice
Leone, G., DeGregori, J., Yan, Z., Jakoi, L., Ishida, S., Williams, R.S., andat the centrosome. J. Cell Biol. 141, 163–174.
Nevins, J.R. (1998). E2F3 activity is regulated during the cell cycle and is
required for the induction of S phase. Genes Dev. 12, 2120–2130.Di Leonardo, A., Khan, S.H., Linke, S.P., Greco, V., Seidita, G., and Wahl,
G.M. (1997). DNA replication in the presence of mitotic spindle inhibitors in
Leone, G., Nuckolls, F., Ishida, S., Adams, M., Sears, R., Jakoi, L., Miron,human and mouse fibroblasts lacking either p53 pr pRB function. Cancer
A., and Nevins, J.R. (2000). Identification of a novel E2F3 product suggestsRes. 57, 1013–1019.
a mechanism for determining specificity of repression by Rb proteins. Mol.
Cell. Biol. 20, 3626–3632.Doxsey, S.J., Stein, P., Evans, L., Calarco, P.D., and Kirschner, M. (1994).
Pericentrin, a highly conserved centrosome protein involved in microtubule
Leone, G., Sears, R., Huang, E., Rempel, R., Nuckolls, F., Park, C.-H., Gian-organization. Cell 76, 639–650.
grande, P., Wu, L., Saavedra, H.I., Field, S.J., et al. (2001). Myc requires
distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105–113.Duensing, S., Lee, L.Y., Duensing, A., Basile, J., Piboonniyom, S., Gonzalez,
S., Crum, C.P., and Munger, K. (2000). The human papillomavirus type 16
Lingle, W.L., and Salisbury, J.L. (1999). Altered centrosome structure is
E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic
associated with abnormal mitoses in human breast tumors. Am. J. Pathol.
instability by uncoupling centrosome duplication from the cell division cycle.
155, 1941–1951.
Proc. Natl. Acad. Sci. USA 97, 10002–10007.
Lingle, W.L., Lutz, W.H., Ingle, J.N., Maihle, N.J., and Salisbury, J.L. (1998).
Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston,
Centrosome hypertrophy in human breast tumors: implications for genomic
D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions in mice to
stability and cell polarity. Proc. Natl. Acad. Sci. USA 95, 2950–2955.
promote apoptosis and suppress proliferation. Cell 85, 549–561.
Lingle, W.L., Barrett, S.L., Negron, V.C., D’Assoro, A.B., Boeneman, K., Liu,
Fisk, H.A., and Winey, M. (2001). The mouse Mps1p-like kinase regulates W., Whitehead, C.M., Reynolds, C., and Salisbury, J.L. (2002). Centrosome
centrosome duplication. Cell 106, 95–104. amplification drives chromosomal instability in breast tumor development.
Proc. Natl. Acad. Sci. USA 99, 1978–1983.Fodde, R., Kuipers, J., Rosenberg, C., Smits, R., Kielman, M., Gaspar, C.,
van Es, J.H., Breukel, C., Wiegant, J., Giles, R.H., and Clevers, H. (2001). Mantel, C., Braun, S.E., Reid, S., Henegariu, O., Liu, L., Hangoc, G., and
Mutations in the APC tumour suppressor gene cause chromosomal instabil- Broxmeyer, H.E. (1999). p21(cip-1/waf-1) deficiency causes deformed nu-
ity. Nat. Cell Biol. 3, 433–438. clear architecture, centriole overduplication, polyploidy, and relaxed microtu-
bule damage checkpoints in human hematopoietic cells. Blood 93, 1390–Fukasawa, K., and Vande Woude, G.F. (1997). Synergy between the Mos/
1398.mitogen-activated protein kinase pathway and loss of p53 function in trans-
formation and chromosome instability. Mol. Cell. Biol. 17, 506–518. Martineau, S.N., Andreassen, P.R., and Margolis, R.L. (1995). Delay of HeLa
cell cleavage into interphase using dihydrocytochalasin B: retention of aFukasawa, K., Choi, T., Kuriyama, R., Rulong, S., and Vande Woude, G.F.
postmitotic spindle and telophase disc correlates with synchronous cleavage(1996). Abnormal centrosome amplification in the absence of p53. Science
recovery. J. Cell Biol. 131, 191–205.271, 1744–1747.
Matsumoto, Y., Hayashi, K., and Nishida, E. (1999). Cyclin-dependent kinaseGaubatz, S., Lindeman, G.J., Ishida, S., Jakoi, L., Nevins, J.R., Livingston,
2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr.D.M., and Rempel, R.E. (2000). E2F4 and E2F5 play an essential role in
Biol. 9, 429–432.pocket protein-mediated G1 control. Mol. Cell 6, 729–735.
Meraldi, P., Lukas, J., Fry, A.M., Bartek, J., and Nigg, E.A. (1999). Centro-Ghadimi, B.M., Sackett, D.L., Difilippantonio, M.J., Schrock, E., Neumann,
some duplication in mammalian somatic cells requires E2F and Cdk2- cyclinT., Jauho, A., Auer, G., and Ried, T. (2000). Centrosome amplification and
A. Nat. Cell Biol. 1, 88–93.instability occurs exclusively in aneuploid, but not in diploid colorectal cancer
cell lines, and correlates with numerical chromosomal aberrations. Genes Meraldi, P., Honda, R., and Nigg, E.A. (2002). Aurora-A overexpression re-
Chromosomes Cancer 27, 183–190. veals tetraploidization as a major route to centrosome amplification in
p53/ cells. EMBO J. 21, 483–492.
Hinchcliffe, E.H., and Sluder, G. (2001). “It takes two to tango”: understanding
how centrosome duplication is regulated throughout the cell cycle. Genes Merdes, A., and Cleveland, D.W. (1997). Pathways of spindle pole formation:
Dev. 15, 1167–1181. different mechanisms; conserved components. J. Cell Biol. 138, 953–956.
Hinchcliffe, E.H., Li, C., Thompson, E.A., Maller, J.L., and Sluder, G. (1999). Moroni, M.C., Hickman, E.S., Denchi, E.L., Caprara, G., Colli, E., Cecconi,
F., Muller, H., and Helin, K. (2001). Apaf-1 is a transcriptional target for E2FRequirement of Cdk2-cyclin E activity for repeated centrosome reproduction
and p53. Nat. Cell Biol. 3, 552–558.in Xenopus egg extracts. Science 283, 851–854.
Muller, H., Bracken, A.P., Vernell, R., Moroni, M.C., Christians, F., Grassilli,Hollander, M.C., Sheikh, M.S., Bulavin, D.V., Lundgren, K., Augeri-Hen-
E., Prosperini, E., Vigo, E., Oliner, J.D., and Helin, K. (2001). E2Fs regulatemueller, L., Shehee, R., Molinaro, T.A., Kim, K.E., Tolosa, E., Ashwell, J.D.,
the expression of genes involved in differentiation, development, prolifera-et al. (1999). Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23,
tion, and apoptosis. Genes Dev. 15, 267–285.176–184.
Mussman, J.G., Horn, H.F., Carroll, P.E., Okuda, M., Tarapore, P., Doneh-Humbert, P.O., Verona, R., Trimarchi, J.M., Rogers, C., Dandapani, S., and
ower, L.A., and Fukasawa, K. (2000). Synergistic induction of centrosomeLees, J.A. (2000). E2f3 is critical for normal cellular proliferation. Genes Dev.
hyperamplification by loss of p53 and cyclin E overexpression. Oncogene14, 690–703.
19, 1635–1646.
Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., and Nevins,
Niculescu, A.B., 3rd, Chen, X., Smeets, M., Hengst, L., Prives, C., and Reed,J.R. (2001). Role for E2F in control of both DNA replication and mitotic
S.I. (1998). Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cellfunctions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21,
cycle transitions: pRb is a critical determinant in blocking DNA replication4684–4699.
and in preventing endoreduplication. Mol. Cell. Biol. 18, 629–643.
Kaplan, K.B., Burds, A.A., Swedlow, J.R., Bekir, S.S., Sorger, P.K., and
Okuda, M., Horn, H.F., Tarapore, P., Tokuyama, Y., Smulian, A.G., Chan,Nathke, I.S. (2001). A role for the Adenomatous Polyposis Coli protein in
P.K., Knudsen, E.S., Hofmann, I.A., Snyder, J.D., Bove, K.E., and Fukasawa,chromosome segregation. Nat. Cell Biol. 3, 429–432.
K. (2000). Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome
Lacey, K.R., Jackson, P.K., and Stearns, T. (1999). Cyclin-dependent kinase duplication. Cell 103, 127–140.
control of centrosome duplication. Proc. Natl. Acad. Sci. USA 96, 2817–2822.
Pihan, G.A., and Doxsey, S.J. (1999). The mitotic machinery as a source of
genetic instability in cancer. Semin. Cancer Biol. 9, 289–302.Lanni, J.S., and Jacks, T. (1998). Characterization of the p53-dependent
CANCER CELL : APRIL 2003 345
A R T I C L E
Pihan, G.A., Purohit, A., Wallace, J., Knecht, H., Woda, B., Quesenberry, Ross, G., and Ashworth, A. (1999). Absence of Brca2 causes genome insta-
bility by chromosome breakage and loss associated with centrosome ampli-P., and Doxsey, S.J. (1998). Centrosome defects and genetic instability in
malignant tumors. Cancer Res. 58, 3974–3985. fication. Curr. Biol. 9, 1107–1110.
Wang, A., Schneider-Broussard, R., Kumar, A.P., MacLeod, M.C., and John-Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R.A., and
son, D.G. (2000). Regulation of BRCA1 expression by the Rb-E2F pathway.Dynlacht, B.D. (2002). E2F integrates cell cycle progression with DNA repair,
J. Biol. Chem. 275, 4532–4536.replication, and G(2)/M checkpoints. Genes Dev. 16, 245–256.
White, R.A., Pan, Z., and Salisbury, J.L. (2000). GFP-centrin as a marker forSaavedra, H.I., Fukasawa, K., Conn, C.W., and Stambrook, P.J. (1999).
centriole dynamics in living cells. Microsc. Res. Tech. 49, 451–457.MAPK mediates RAS-induced chromosome instability. J. Biol. Chem. 274,
38083–38090. Wilde, A., and Zheng, Y. (1999). Stimulation of microtubule aster formation
and spindle assembly by the small GTPase Ran. Science 284, 1359–1362.Saavedra, H.I., Knauf, J.A., Shirokawa, J.M., Wang, J., Ouyang, B., Elisei,
R., Stambrook, P.J., and Fagin, J.A. (2000). The RAS oncogene induces Wu, L., Timmers, C., Maiti, B., Saavedra, H.I., Sang, L., Chong, G.T., Nuck-
genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene olls, F., Giangrande, P., Wright, F.A., Field, S.J., et al. (2001). The E2F1,
19, 3948–3954. E2F2, and E2F3 transcription factors are essential for cellular proliferation.
Nature 414, 457–462.Saavedra, H.I., Wu, L., de Bruin, A., Timmers, C., Rosol, T.J., Weinstein, M.,
Robinson, M.L., and Leone, G. (2002). Specificity of E2F1, E2F2 and E2F3 Xu, X., Weaver, Z., Linke, S.P., Li, C., Gotay, J., Wang, X.W., Harris, C.C.,
in mediating Rb function. Cell Growth Differ. 13, 215–225. Ried, T., and Deng, C.X. (1999). Centrosome amplification and a defective
G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11Spruck, C.H., Won, K.A., and Reed, S.I. (1999). Deregulated cyclin E induces
isoform-deficient cells. Mol. Cell 3, 389–395.
chromosome instability. Nature 401, 297–300.
Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N.J.
Tarapore, P., Horn, H.F., Tokuyama, Y., and Fukasawa, K. (2001). Direct (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85,
regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 537–548.
pathway. Oncogene 20, 3173–3184.
Yamasaki, L., Bronson, R., Williams, B.O., Dyson, N.J., Harlow, E., and
Tokuyama, Y., Horn, H.F., Kawamura, K., Tarapore, P., and Fukasawa, K. Jacks, T. (1998). Loss of E2F-1 reduces tumorigenesis and extends the
(2001). Specific phosphorylation of nucleophosmin on Thr(199) by cyclin- lifespan of Rb1(/) mice. Nat. Genet. 18, 360–364.
dependent kinase 2-cyclin E and its role in centrosome duplication. J. Biol.
Zheng, Y., Wong, M.L., Alberts, B., and Mitchison, T. (1998). PurificationChem. 276, 21529–21537.
and assay of gamma tubulin ring complex. Methods Enzymol. 298, 218–228.
Trimarchi, J.M., and Lees, J.A. (2002). Sibling rivalry in the E2F family. Nat.
Ziebold, U., Reza, T., Caron, A., and Lees, J.A. (2001). E2F3 contributesRev. Mol. Cell Biol. 3, 11–20.
both to the inappropriate proliferation and to the apoptosis arising in Rb
mutant embryos. Genes Dev. 15, 386–391.Tutt, A., Gabriel, A., Bertwistle, D., Connor, F., Paterson, H., Peacock, J.,
346 CANCER CELL : APRIL 2003
